BackMirati Therapeutics Overview

Mirati Therapeutics Profit Margin

Profitability ratio analysis for MRTX.

Quarterly Profit Margin

-987.22%
↑ 69.11% YoY

As of Sep 2023

Annual Profit Margin (TTM)

-1876.47%
↑ 69.99% YoY

Trailing 12 months ending Sep 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin